CDC advisory panel recommends Pfizer boosters for older, some high-risk Americans
Advisors to the Centers for Disease Control and Prevention voted unanimously on Thursday to recommend booster doses of Pfizer's COVID-19 vaccine for Americans 65 and older, residents of long-term care facilities, and people between 50 and 64 with underlying health conditions.
On Wednesday, the Food and Drug Administration authorized boosters for people 65 and older, frontline workers, and individuals with underlying conditions that put them at high risk of getting severe COVID if infected.
The CDC advisory panel said the boosters should come at least six months after a person received their second dose of the vaccine. The CDC typically adopts the recommendations of the panel, and if CDC Director Rochelle Walensky decides to follow the guidance, that's the final step in getting boosters into the arms of millions of Americans.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Magazine solutions - February 7, 2025
Puzzles and Quizzes Issue - February 7, 2025
By The Week US Published
-
Magazine printables - February 7, 2025
Puzzles and Quizzes Issue - February 7, 2025
By The Week US Published
-
Hands-on experiences that let travelers connect with the culture
The Week Recommends Sharpen your sense of place through these engaging activities
By Catherine Garcia, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published